Clinical Trial Update: A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cisplatin plus radiotherapy to cetuximab plus radiotherapy in locally advanced head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• Radiotherapy

Snippet

Sponsor: Lund University Hospital | Conditions: Locally Advanced Head and Neck Cancer | Phase 3 | Status: COMPLETED